mechanism trypanosoma brucei gambiense resistance human serum 
african parasite trypanosoma brucei gambiense accounts % human sleeping sickness cases t b gambiense resists specific human innate immunity acting several tsetsefly-transmitted trypanosome species t b brucei causative agent nagana disease cattle human immunity african trypanosomes due two serum complexes designated trypanolytic factors tlf contain haptoglobin-related protein hpr apolipoprotein li apol1- whereas hpr association haemoglobin hb allows tlf binding uptake via trypanosome receptor tbhphbr ref tlf enters trypanosomes independently tbhphbr refs apol1 kills trypanosomes insertion endosomal/lysosomal membranes report t b gambiense resists tlfs via hydrophobic beta-sheet t b gambiense-specific glycoprotein tgsgp prevents apol1 toxicity induces stiffening membranes upon interaction lipids two additional features contribute resistance tlfs: reduction sensitivity apol1 requiring cysteine protease activity tbhphbr inactivation due l210s substitution according multifactorial defence mechanism transgenic expression t b brucei tbhphbr t b gambiense cause parasite lysis normal human serum however transgenic parasites killed hypohaptoglobinaemic serum high tlf uptake absence haptoglobin hp competes hb receptor binding tbhphbr inactivation preventing high apol1 loading hypohaptoglobinaemic serum may evolved overlapping endemic area t b gambiense infection malaria main cause haemolysis-induced hypohaptoglobinaemia western central africa 
